Purpura, Thrombocytopenic, Idiopathic Concept

subject area of

• A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia  Academic Article
• A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia  Academic Article
• A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura  Academic Article
• A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura  Academic Article
• A systematic evaluation of laboratory testing for drug‐induced immune thrombocytopenia  Academic Article
• A user guide to the American Society of Hematology clinical practice guidelines  Academic Article
• Acute idiopathic thrombocytopenic purpura--management in childhood.  Academic Article
• All-trans retinoic acid for treating immune thrombocytopenia: new purpose for an old drug?  Academic Article
• Alloimmune Thrombocytopenia after Organ Transplantation  Academic Article
• American Society of Hematology 2019 guidelines for immune thrombocytopenia  Academic Article
• An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia  Academic Article
• Antibody binding to megakaryocytesin vivoin patients with immune thrombocytopenia  Academic Article
• Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein  Academic Article
• Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia  Conference Paper
• Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma  Conference Paper
• Autoimmune heparin‐induced thrombocytopenia  Academic Article
• Autoimmune heparin‐induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin  Academic Article
• Bacterial infection-associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies  Academic Article
• Bleeding complications in immune thrombocytopenia  Academic Article
• Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.  Academic Article
• Chronic Immune Thrombocytopenic Purpura in Children  Academic Article
• Circulating heparin‐like anticoagulants: Case report and review of literature  Academic Article
• Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura  Academic Article
• Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy  Academic Article
• Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia  Academic Article
• Current Controversies Concerning the Measurement of Platelet-Associated IgG  Academic Article
• Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura  Academic Article
• Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders  Academic Article
• Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology  Academic Article
• Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia  Academic Article
• Development of Disease-Specific Health-Related Quality-of-Life Instruments for Children With Immune Thrombocytopenic Purpura and Their Parents  Academic Article
• Diagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of Hematology  Academic Article
• Diagnosis and treatment of idiopathic thrombocytopenic purpura. American Society of Hematology ITP Practice Guideline Panel.  Academic Article
• Difficulties in establishing the diagnosis of immune thrombocytopenia: An agreement study  Academic Article
• Does Helicobacter pylori Eradication Therapy Result in a Platelet Count Improvement in Adults with Immune Thrombocytopenic Purpura Regardless of H pylori Infection?  Academic Article
• Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia  Academic Article
• Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia  Academic Article
• Epidemiology of VITT.  Academic Article
• Fatigue in children and adolescents with immune thrombocytopenia  Academic Article
• FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia  Academic Article
• Fetal and Maternal Thrombocytopenia  Academic Article
• First-Line Therapy for Immune Thrombocytopenia  Academic Article
• Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials  Academic Article
• Frequency and utility of bone marrow examination in relapsed/refractory immune thrombocytopenia  Academic Article
• HLA-DR expression by platelets in acute idiopathic thrombocytopenic purpura  Academic Article
• Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal—Not Identical—Twins  Academic Article
• High-Dose Intravenous Immune Globulin and the Response to Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura  Academic Article
• High-Dose Intravenous Immune Globulin and the Response to Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura  Academic Article
• High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis  Academic Article
• How do we diagnose immune thrombocytopenia in 2018?  Academic Article
• IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life  Academic Article
• Idiopathic immune thrombocytopenic purpura: An update  Academic Article
• Idiopathic thrombocytopenic purpura complicating pregnancy  Academic Article
• Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]  Academic Article
• Immune thrombocytopenia ( ITP ) World Impact Survey ( I‐WISh ): Impact of ITP on health‐related quality of life  Academic Article
• Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment  Academic Article
• Immune thrombocytopenia: Getting back to basics  Academic Article
• Immune thrombocytopenic purpura associated with fingolimod  Academic Article
• Incidence of portal vein thrombosis after laparoscopic splenectomy.  Academic Article
• Increased cytotoxic potential of CD8 ⁺ T cells in immune thrombocytopenia  Academic Article
• Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia  Academic Article
• International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee  Academic Article
• Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by Fcγ RIIa and Fcγ RIIIa polymorphisms  Academic Article
• Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group.  Academic Article
• Laboratory diagnosis of heparin‐induced thrombocytopenia  Academic Article
• Laboratory investigation of immune thrombocytopenia.  Academic Article
• Laboratory testing for VITT antibodies  Academic Article
• Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura  Academic Article
• Laparoscopic splenectomy: Outcomes and lessons learned from over 200 cases  Academic Article
• Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program  Academic Article
• Management of idiopathic thrombocytopenic purpura in pregnancy  Academic Article
• Management of major bleeds in patients with immune thrombocytopenia  Academic Article
• Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score  Academic Article
• Measurement of endogenous and exogenous alpha-granular platelet proteins in patients with immune and nonimmune thrombocytopenia  Academic Article
• Megakaryocyte apoptosis in immune thrombocytopenia  Academic Article
• Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia  Academic Article
• Monovalent Fc receptor blockade by an anti–Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity  Academic Article
• New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses  Academic Article
• No apparent association between mRNA COVID-19 vaccination and venous thromboembolism  Academic Article
• Novel treatments for immune thrombocytopenia  Academic Article
• Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters  Academic Article
• Pediatric refractory immune thrombocytopenia: A systematic review  Academic Article
• Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL ® HIT-Ab (PF4-H) ] for the diagnosis of immune heparin-induced thrombocytopenia  Academic Article
• Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria  Academic Article
• Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale  Academic Article
• Physician decision making in selection of second-line treatments in immune thrombocytopenia in children  Academic Article
• Piecing Together the Humoral and Cellular Mechanisms of Immune Thrombocytopenia  Academic Article
• Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia  Academic Article
• Platelet count or bleeding as the outcome in ITP trials?  Academic Article
• Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review  Academic Article
• Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor  Academic Article
• Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia  Academic Article
• Platelet-activating anti-PF4 disorders: An overview  Academic Article
• Positioning new treatments in the management of immune thrombocytopenia  Academic Article
• Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis  Academic Article
• Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition  Academic Article
• Pregnancy in Patients With Idiopathic Thrombocytopenic Purpura  Academic Article
• Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia  Academic Article
• Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies  Academic Article
• Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia  Academic Article
• Recommendations for standardization of laboratory testing for drug‐induced immune thrombocytopenia: communication from the SSC of the ISTH  Academic Article
• Reconnaître, traiter et signaler les cas de thrombocytopénie immunitaire thrombotique induite par un vaccin  Academic Article
• Response to “treatment of childhood chronic ITP”  Academic Article
• Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia  Academic Article
• Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis  Academic Article
• Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes  Academic Article
• Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders  Academic Article
• Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review  Academic Article
• Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: reply  Academic Article
• Shared Decision Making in the Management of Children With Newly Diagnosed Immune Thrombocytopenia  Academic Article
• Splenectomy for immune thrombocytopenia: down but not out  Academic Article
• Splenic Radiation for Corticosteroid-resistant Immune Thrombocytopenia  Academic Article
• Spontaneous Intramural Esophageal Hematoma in Association With Idiopathic Thrombocytopenic Purpura: A Cause of Non-Cardiac Chest Pain  Academic Article
• Sports Participation in Children and Adolescents with Immune Thrombocytopenia (ITP)  Academic Article
• Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group  Academic Article
• Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists  Academic Article
• Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura  Academic Article
• T cell–mediated autoimmunity in immune thrombocytopenia  Academic Article
• Testing for heparin‐induced thrombocytopenia: are we there yet?  Academic Article
• The Canadian Experience Using Plasma Exchange for Immune Thrombocytopenic Purpura  Academic Article
• The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura  Academic Article
• The Serological Investigation of Patients with Autoimmune Thrombocytopenia  Academic Article
• The alloimmune thrombocytopenic syndromes  Academic Article
• The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia  Academic Article
• The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia  Academic Article
• The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta‐analysis of a diagnostic test  Academic Article
• The use of electron microscopy in the investigation of the ultrastructural morphology of immune thrombocytopenic purpura platelets  Academic Article
• Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination  Academic Article
• Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)  Academic Article
• Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy  Academic Article
• Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder  Academic Article
• Updated international consensus report on the investigation and management of primary immune thrombocytopenia  Academic Article
• Use of Intravenous Gammaglobulin as an Immune Replacement and an Immune Suppressant  Academic Article
• Vaccine-induced immune thrombotic thrombocytopenia (VITT)  Academic Article
• Vaccine‐induced immune thrombotic thrombocytopenia (VITT) ‐ update on diagnosis and management considering different resources: Response to Comment from Yamada et al  Academic Article
• Validity, Reliability, and Responsiveness of a New Measure of Health-Related Quality of Life in Children with Immune Thrombocytopenic Purpura: The Kids’ ITP Tools  Academic Article
• “Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia”: reply  Academic Article